129 related articles for article (PubMed ID: 21183765)
1. Baseline C-reactive protein serum levels and in-stent restenosis pattern after m-TOR inhibitors drug-eluting stent implantation.
Niccoli G; Conte M; Cosentino N; Todaro D; Brugaletta S; Montone RA; Minelli S; Fracassi F; Galiffa V; Leone AM; Burzotta F; Porto I; Trani C; Crea F
J Invasive Cardiol; 2011 Jan; 23(1):16-20. PubMed ID: 21183765
[TBL] [Abstract][Full Text] [Related]
2. Prognostic impact of preprocedural C reactive protein levels on 6-month angiographic and 1-year clinical outcomes after drug-eluting stent implantation.
Park DW; Lee CW; Yun SC; Kim YH; Hong MK; Kim JJ; Park SW; Park SJ
Heart; 2007 Sep; 93(9):1087-92. PubMed ID: 17309906
[TBL] [Abstract][Full Text] [Related]
3. Predictor of subsequent target lesion revascularization in patients with drug-eluting stent restenosis undergoing percutaneous coronary intervention.
Takasawa Y; Iijima R; Shiba M; Nakamura M; Sugi K
J Cardiol; 2010 May; 55(3):391-6. PubMed ID: 20350511
[TBL] [Abstract][Full Text] [Related]
4. Independent predictors of in-stent restenosis after drug-eluting stent implantation for ostial right coronary artery lesions.
Watanabe Y; Takagi K; Naganuma T; Kawamoto H; Fujino Y; Ishiguro H; Tahara S; Kurita N; Hosawa K; Nakamura S; Nakamura S
Int J Cardiol; 2017 Aug; 240():108-113. PubMed ID: 28476515
[TBL] [Abstract][Full Text] [Related]
5. Inverse Relationship between Serum VEGF Levels and Late In-Stent Restenosis of Drug-Eluting Stents.
Yin J; Shen L; Ji M; Wu Y; Cai S; Chen J; Yao Z; Ge J
Biomed Res Int; 2017; 2017():8730271. PubMed ID: 28373989
[TBL] [Abstract][Full Text] [Related]
6. Do pre-procedural laboratory parameters predict drug-eluting stent restenosis?
Tanındı A; Ekici B; Töre HF
Turk Kardiyol Dern Ars; 2015 Jul; 43(5):457-64. PubMed ID: 26148078
[TBL] [Abstract][Full Text] [Related]
7. Cystatin C associates with the prediction of in-stent restenosis among patients receiving stent implantation: results of the 1-year follow-up.
Zhao C; Yang L; Mao L; Zhong L; Li X; Wei S
Coron Artery Dis; 2013 Aug; 24(5):357-60. PubMed ID: 23835667
[TBL] [Abstract][Full Text] [Related]
8. Randomized trial of optimal treatment strategies for in-stent restenosis after drug-eluting stent implantation.
Song HG; Park DW; Kim YH; Ahn JM; Kim WJ; Lee JY; Kang SJ; Lee SW; Lee CW; Park SW; Han S; Seong IW; Lee NH; Lee BK; Lee K; Lee SW; Nah DY; Park SJ
J Am Coll Cardiol; 2012 Mar; 59(12):1093-100. PubMed ID: 22421303
[TBL] [Abstract][Full Text] [Related]
9. Angiographic patterns of drug-eluting stent restenosis and one-year outcomes after treatment with repeated percutaneous coronary intervention.
Solinas E; Dangas G; Kirtane AJ; Lansky AJ; Franklin-Bond T; Boland P; Syros G; Kim YH; Gupta A; Mintz G; Fahy M; Collins M; Kodali S; Stone GW; Moses JW; Leon MB; Mehran R
Am J Cardiol; 2008 Aug; 102(3):311-5. PubMed ID: 18638592
[TBL] [Abstract][Full Text] [Related]
10. Role of red blood cell distribution in predicting drug-eluting stent restenosis in patients with stable angina pectoris after coronary stenting.
Zhao K; Li YJ; Gao S
Coron Artery Dis; 2015 May; 26(3):220-4. PubMed ID: 25647458
[TBL] [Abstract][Full Text] [Related]
11. Comparison of 2-year outcomes of repeated second-generation drug-eluting stent implantation for focal-type versus nonfocal-type in-stent restenosis.
Zhu W; Li J; Luo H; Wang G; Hua Q
Coron Artery Dis; 2015 Nov; 26(7):587-91. PubMed ID: 26166020
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Impact of 9-Month High-Sensitivity C-Reactive Protein Levels on Long-Term Clinical Outcomes and In-Stent Restenosis in Patients at 9 Months after Drug-Eluting Stent Implantation.
Hsieh IC; Chen CC; Hsieh MJ; Yang CH; Chen DY; Chang SH; Wang CY; Lee CH; Tsai ML
PLoS One; 2015; 10(9):e0138512. PubMed ID: 26406989
[TBL] [Abstract][Full Text] [Related]
13. Comparison of angiographic patterns of in-stent restenosis between sirolimus- and paclitaxel-eluting stent.
Park CB; Hong MK; Kim YH; Park DW; Han KH; Lee CW; Kang DH; Song JK; Kim JJ; Park SW; Park SJ
Int J Cardiol; 2007 Sep; 120(3):387-90. PubMed ID: 17291608
[TBL] [Abstract][Full Text] [Related]
14. The impact of lesion length and vessel size on outcomes after sirolimus-eluting stent implantation for in-stent restenosis.
Habara S; Mitsudo K; Goto T; Kadota K; Fujii S; Yamamoto H; Kato H; Takenaka S; Fuku Y; Hosogi S; Hirono A; Yamamoto K; Tanaka H; Hasegawa D; Nakamura Y; Tasaka H; Otsuru S; Okamoto Y; Yamada C; Miyamoto M; Inoue K
Heart; 2008 Sep; 94(9):1162-5. PubMed ID: 18032460
[TBL] [Abstract][Full Text] [Related]
15. Clinical outcome of percutaneous treatment of in-stent restenosis with drug-eluting stents: results from the first phase of the prospective multicentre German DES.DE registry.
Abdel-Wahab M; Nienaber CA; Mostafa AE; Sabin G; Tebbe U; Hochadel M; Senges J; Akin I; Kuck KH; Hamm C; Richardt G;
EuroIntervention; 2011 Jun; 7(2):201-8. PubMed ID: 21646062
[TBL] [Abstract][Full Text] [Related]
16. Implantation of a drug-eluting stent with a different drug (switch strategy) in patients with drug-eluting stent restenosis. Results from a prospective multicenter study (RIBS III [Restenosis Intra-Stent: Balloon Angioplasty Versus Drug-Eluting Stent]).
Alfonso F; Pérez-Vizcayno MJ; Dutary J; Zueco J; Cequier A; García-Touchard A; Martí V; Lozano I; Angel J; Hernández JM; López-Mínguez JR; Melgares R; Moreno R; Seidelberger B; Fernández C; Hernandez R;
JACC Cardiovasc Interv; 2012 Jul; 5(7):728-37. PubMed ID: 22814777
[TBL] [Abstract][Full Text] [Related]
17. Comparison of sirolimus versus paclitaxel eluting stents for treatment of coronary in-stent restenosis.
Airoldi F; Briguori C; Iakovou I; Stankovic G; Biondi-Zoccai G; Carlino M; Chieffo A; Montorfano M; Cosgrave J; Michev I; Rogacka R; Sangiorgi GM; Colombo A
Am J Cardiol; 2006 Apr; 97(8):1182-7. PubMed ID: 16616023
[TBL] [Abstract][Full Text] [Related]
18. Paclitaxel-eluting balloon versus everolimus-eluting stent for treatment of drug-eluting stent restenosis.
Almalla M; Schröder J; Pross V; Marx N; Hoffmann R
Catheter Cardiovasc Interv; 2014 May; 83(6):881-7. PubMed ID: 23765557
[TBL] [Abstract][Full Text] [Related]
19. A comparison of angiographic and clinical outcomes after sirolimus-eluting versus paclitaxel-eluting stents for the treatment of in-stent restenosis.
Li JJ; Xu B; Yang YJ; Ma WH; Chen JL; Qiao SB; Qin XW; Yao M; Liu HB; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J; Xia R; Gao RL
Chin Med J (Engl); 2006 Jul; 119(13):1059-64. PubMed ID: 16834923
[TBL] [Abstract][Full Text] [Related]
20. Increased restenosis rate after implantation of drug-eluting stents in patients with elevated serum activity of matrix metalloproteinase-2 and -9.
Katsaros KM; Kastl SP; Zorn G; Maurer G; Wojta J; Huber K; Christ G; Speidl WS
JACC Cardiovasc Interv; 2010 Jan; 3(1):90-7. PubMed ID: 20129576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
